the epidemiology, management, and the associated burden of related conditions in alopecia areata

Conditions: Alopecia Areata; Depressive Episode; Recurrent Depressive Disorder; Anxiety Disorders; Atopic Dermatitis; Allergic Rhinitis; Asthma; Crohn Disease; Ulcerative Colitis; Pernicious Anemia; Type 1 Diabetes; Hashimoto Thyroiditis; Graves Disease; Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus; Polymyalgia Rheumatica; Sjogren's Syndrome; Psoriasis; Vitiligo; Multiple Sclerosis; Celiac Disease; Upper Respiratory Tract Infection; Influenza; Lower Resp Tract Infection; Acute Bronchitis; Pneumonia; Gastrointestinal Infection; Skin Infection; Urinary Tract Infections; Genital Infection; Herpes Zoster; Herpes Simplex; Infection; Infection Viral

Summary: this study series consists of four related studies and aims to explore and describe many important elements of alopecia areata over three key areas: (1) the current epidemiology of alopecia areata, (2) the prevalence and incidence of psychiatric co-morbidities in people with alopecia areata, (3) the prevalence and incidence of autoimmune and atopic conditions in people with alopecia areata, and (4) the incidence of common infections in people with alopecia areata.

the overall purpose of the first study (study 1) is to describe the epidemiology of alopecia areata (aa) and to assess the current level of primary care service utilisation and management patterns associated with patients diagnosed with aa. the overall purpose of the second study (study 2) is to assess the prevalence and incidence of mental health conditions (depressive episodes, recurrent depressive disorder and anxiety disorder) in adult patients diagnosed with aa relative to a control population of patients without a diagnosis of aa. in addition, the study will determine both the treatment, 'sick day' and unemployment burden. treatment burden comprises that of medications and psychological interventions used to treat mental health conditions in adult patients diagnosed with alopecia areata. the overall purpose of the third study (study 3) is to assess the prevalence and incidence of atopic and autoimmune conditions in adult patients diagnosed with aa relative to a control population of patients without aa. the overall purpose of the fourth study (study 4) is to assess the incidence of common infections in adult patients diagnosed with aa relative to a control population of patients without aa.

Eligibility criteria:
inclusion criteria: * patients contributing to royal college of general practitioners research and surveillance centre(rcgp rcs) primary care database between january 1, 2009 and december 31, 2018, will be eligible for inclusion. * only patients aged ≥18 will be eligible for studies 2 and 3. * only patients aged ≥ 18 and ≤ 65 will be included in the unemployment and sick day analysis (study 2) exclusion criteria: * people with the alternative non-aa diagnoses. * people with aa diagnosis within 6 months of registration. * people with less than 1 year of follow up available

Keywords: alopecia areata common mental health conditions depression anxiety autoimmune disease atopic conditions epidemiology incidence prevalence infection